These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35115922)

  • 1. Intravenous Immunoglobulin Combined With Corticosteroids for the Treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Propensity-Matched Retrospective Study in China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Front Pharmacol; 2021; 12():750173. PubMed ID: 35115922
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
    Chen J; Wang B; Zeng Y; Xu H
    Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study.
    Zhang J; Lu CW; Chen CB; Wang CW; Chen WT; Cheng B; Ji C; Chung WH
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1295-1304.e6. PubMed ID: 35131514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic epidermal necrolysis: performance of SCORTEN and the score-based comparison of the efficacy of corticosteroid therapy and intravenous immunoglobulin combined therapy in China.
    Zhu QY; Ma L; Luo XQ; Huang HY
    J Burn Care Res; 2012; 33(6):e295-308. PubMed ID: 22955159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Plasmapheresis vs Immunoglobulin as First Treatment After Ineffective Systemic Corticosteroid Therapy for Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Miyamoto Y; Ohbe H; Kumazawa R; Matsui H; Fushimi K; Yasunaga H; Ohta B
    JAMA Dermatol; 2023 May; 159(5):481-487. PubMed ID: 36884227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Aihara M; Kano Y; Fujita H; Kambara T; Matsukura S; Katayama I; Azukizawa H; Miyachi Y; Endo Y; Asada H; Miyagawa F; Morita E; Kaneko S; Abe R; Ochiai T; Sueki H; Watanabe H; Nagao K; Aoyama Y; Sayama K; Hashimoto K; Shiohara T;
    J Dermatol; 2015 Aug; 42(8):768-77. PubMed ID: 25982480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis.
    Stella M; Clemente A; Bollero D; Risso D; Dalmasso P
    Burns; 2007 Jun; 33(4):452-9. PubMed ID: 17475410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Dermatological Treatments for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japan.
    Hsieh MH; Watanabe T; Aihara M
    Front Med (Lausanne); 2021; 8():636924. PubMed ID: 34395458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson Syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People's Republic of China.
    Sun J; Liu J; Gong QL; Ding GZ; Ma LW; Zhang LC; Lu Y
    Drug Des Devel Ther; 2014; 8():2539-47. PubMed ID: 25548516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Intravenous Immunoglobulin Combined with Corticosteroid on the Progression of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Meta-Analysis.
    Ye LP; Zhang C; Zhu QX
    PLoS One; 2016; 11(11):e0167120. PubMed ID: 27902746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.
    Kirchhof MG; Miliszewski MA; Sikora S; Papp A; Dutz JP
    J Am Acad Dermatol; 2014 Nov; 71(5):941-7. PubMed ID: 25087214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective analysis of Stevens-Johnson syndrome/toxic epidermal necrolysis treated with corticosteroids.
    Liu W; Nie X; Zhang L
    Int J Dermatol; 2016 Dec; 55(12):1408-1413. PubMed ID: 27652522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality.
    Roujeau JC; Bastuji-Garin S
    Ther Adv Drug Saf; 2011 Jun; 2(3):87-94. PubMed ID: 25083204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre.
    Lee HY; Lim YL; Thirumoorthy T; Pang SM
    Br J Dermatol; 2013 Dec; 169(6):1304-9. PubMed ID: 24007192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 10-year retrospective cohort study of the management of toxic epidermal necrolysis and Stevens-Johnson syndrome in a New South Wales state referral hospital from 2006 to 2016.
    Chan L; Cook DK
    Int J Dermatol; 2019 Oct; 58(10):1141-1147. PubMed ID: 30908601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
    Schneider JA; Cohen PR
    Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Early Systemic Corticosteroid Therapy with Mortality in Patients with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis: A Retrospective Cohort Study Using a Nationwide Claims Database.
    Morita K; Matsui H; Michihata N; Fushimi K; Yasunaga H
    Am J Clin Dermatol; 2019 Aug; 20(4):579-592. PubMed ID: 31041733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.